ABSTRACT
Purpose
Longitudinal evaluation of acute exudative polymorphous paraneoplastic vitelliform maculopathy (AEPPVM) following diagnosis and treatment of metastatic melanoma.
Methods
Case report of a 47-year-old male with unknown primary metastatic melanoma and AEPPVM monitored before and during melanoma treatment using clinical exam, retinal imaging, and electroretinograms (ERG). Genetic testing and autoantibody panels were performed.
Results
He presented within a month of metastatic melanoma diagnosis with numerous bilateral vitelliform lesions in the posterior pole, consistent with AEPPVM. Metastatic disease was treated with immunotherapy, radiosurgery, and radiation over 48 months. Maculopathy and metastatic disease improved and worsened in parallel. Genetic testing was negative for bestrophin-1. An autoantibody panel was positive for anti-recoverin and transducin-α.
Conclusion
AEPPVM is an uncommon paraneoplastic retinopathy found in patients with metastatic malignancy. To our knowledge, this is the first report demonstrating a temporal association between metastatic disease activity and quantifiable changes in retinal imaging over a 4-year period.
Declaration of Interest
Claire M. Mueller: None
Sara Hojjatie: None
David H. Lawson: None
Nieraj Jain: Funded by Foundation Fighting Blindness CD-C-0918-0748-EEC
Joshua Robinson: None
Mohammad Khan: None
Melinda Yushak: Winship Cancer Institute Start Up Funds (source of funding for genetic testing)
Ghazala A. D. O’Keefe: Eyepoint pharmaceuticals, advisory board.